Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot

Abstract

Objective: Despite the implementation of quality assurance procedures, current clinical trial management processes are time-consuming, costly, and often susceptible to error. This can result in limited trust, transparency, and process inefficiencies, without true patient empowerment. The objective of this study was to determine whether blockchain technology could enforce trust, transparency, and patient empowerment in the clinical trial data management process, while reducing trial cost. Design: In this proof of concept pilot, we deployed a Hyperledger Fabric-based blockchain system in an active clinical trial setting to assess the impact of blockchain technology on mean monitoring visit time and cost, non-compliances, and user experience. Using a parallel study design, we compared differences between blockchain technology and standard methodology. Results: A total of 12 trial participants, seven study coordinators and three clinical research associates across five sites participated in the pilot. Blockchain technology significantly reduces total mean monitoring visit time and cost versus standard trial management (475 to 7 min; P = 0.001; €722 to €10; P = 0.001 per participant/visit, respectively), while enhancing patient trust, transparency, and empowerment in 91, 82 and 63% of the patients, respectively. No difference in non-compliances as a marker of trial quality was detected. Conclusion: Blockchain technology holds promise to improve patient-centricity and to reduce trial cost compared to conventional clinical trial management. The ability of this technology to improve trial quality warrants further investigation.

Non-Fungible Tokens for Organoids: Decentralized Biobanking to Empower Patients in Biospecimen Research

“…Alternative approaches to develop technologies for improving patient engagement in research are focused on clinical research, 21 where patients are active participants. By contrast, most organoid research activity uses de-identified samples, and translational scientists are not accustomed to communicating with patients, who may not be aware of the nature of their contributions to biobanking after one-time broad consent.…”

Leveraging Decentralized Clinical Trial Management Systems (dCTMS) to Advance Science: Exploring Challenges related to the Diffusion of Innovation and its Execution

“…Data also suggests that blockchain technology reduces monitoring visit time and cost while improving patient trust and sense of empowerment compared to conventional clinical trial management. 10 …”

Increasing patient participation in oncology clinical trials

“…Therefore, using a blockchain system, patients opt‐in and wait for notification of matched potential eligible trials to participate. 59 , 60 , 61 …”

“…Selected patients will be notified by the master smart contract for availability of clinical trials and for patient authorization to allow the eligible trial sponsor to access their electronic health records to double check recruitment criteria. Therefore, using a blockchain system, patients opt‐in and wait for notification of matched potential eligible trials to participate 59–61 …”

“…Therefore, using a blockchain system, patients opt-in and wait for notification of matched potential eligible trials to participate. [59][60][61] More broadly, digital health technologies can be used for:…”